— Know what they know.
Not Investment Advice

CTSO NASDAQ

Cytosorbents Corporation
1W: -12.1% 1M: -49.9% 3M: -55.2% YTD: -70.7% 1Y: -79.4% 3Y: -90.0% 5Y: -97.6%
$4.05
-0.14 (-3.23%)
 
Weekly Expected Move ±10.2%
$3 $3 $4 $4 $5
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 32 · $12.7M mcap · 3M float · 0.453% daily turnover · Short 47% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.2 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -46.3%  ·  5Y Avg: -63.7%
Cost Advantage
39
Intangibles
55
Switching Cost
31
Network Effect
44
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CTSO shows a Weak competitive edge (41.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -46.3% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CTSO receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-09-08 B- C
2026-08-07 C B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 15 Grade D
Profitability
20
Balance Sheet
14
Earnings Quality
27
Growth
35
Value
15
Momentum
37
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CTSO scores highest in Momentum (37/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-12.13
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✗ ✓ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-3.65
Unlikely Manipulator
Ohlson O-Score
-1.50
Bankruptcy prob: 18.3%
Moderate
Credit Rating
CCC
Score: 15.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.57x
Accruals: -18.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CTSO scores -12.13, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CTSO scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CTSO's score of -3.65 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CTSO's implied 18.3% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CTSO receives an estimated rating of CCC (score: 15.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.70x
PEG
0.01x
P/S
0.34x
P/B
-16.94x
P/FCF
-2.25x
P/OCF
—
EV/EBITDA
-3.12x
EV/Revenue
1.22x
EV/EBIT
-2.93x
EV/FCF
-4.36x
Earnings Yield
-77.54%
FCF Yield
-44.38%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CTSO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.978
NI / EBT
×
Interest Burden
1.201
EBT / EBIT
×
EBIT Margin
-0.416
EBIT / Rev
×
Asset Turnover
0.866
Rev / Assets
×
Equity Multiplier
7.933
Assets / Equity
=
ROE
-336.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CTSO's ROE of -336.2% is driven by financial leverage (equity multiplier: 7.93x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 0.98 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.85
Median 1Y
$1.70
5th Pctile
$0.45
95th Pctile
$6.36
Ann. Volatility
81.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Phillip P. Chan,
MD, PhD Chief Executive Officer
$502,165 $105,600 $808,431
Vincent J. Capponi,
MS President and Chief Operating Officer
$460,040 $89,100 $714,372
Efthymios N. Deliargyris,
MD Chief Medical Officer
$432,586 $70,000 $663,455
Peter J. Mariani
Chief Financial Officer
$442,000 $71,500 $659,872

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $808,431
Avg Employee Cost (SGA/emp): $276,318
Employees: 129

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
129
-13.4% YoY
Revenue / Employee
$287,310
Rev: $37,063,000
Profit / Employee
$-63,550
NI: $-8,198,000
SGA / Employee
$276,318
Avg labor cost proxy
R&D / Employee
$39,419
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -21.1% -34.6% -44.3% -58.3% -75.4% -67.0% -73.9% -73.8% -81.3% -98.2% -1.2% -1.3% -1.2% -1.2% -95.5% -68.8% -96.1% -96.4% -1.4% -3.4% -3.36%
ROA -16.0% -27.4% -34.4% -42.0% -52.6% -43.0% -44.3% -42.8% -42.7% -49.5% -52.7% -48.6% -39.5% -40.9% -32.7% -19.2% -22.6% -17.9% -25.9% -42.4% -42.38%
ROIC -53.8% -74.1% -83.9% -79.5% -91.5% -79.1% -88.9% -81.1% -78.9% -90.5% -79.8% -56.8% -51.5% -37.9% -42.0% -44.3% -39.8% -39.1% -64.8% -46.3% -46.34%
ROCE -20.4% -31.3% -39.9% -50.5% -65.7% -58.3% -66.5% -70.3% -83.5% -78.7% -85.2% -60.9% -47.8% -55.6% -45.6% -47.7% -54.4% -44.0% -64.2% -1.1% -1.11%
Gross Margin 72.3% 74.2% 71.3% 58.2% 30.5% 61.3% 57.7% 63.9% 58.7% 68.1% 76.5% 73.5% 52.3% 1.0% 71.1% 70.9% 70.3% 73.7% 69.2% 73.2% 73.18%
Operating Margin -60.7% -88.7% -98.3% -98.4% -1.4% -67.7% -83.5% -69.6% -94.8% -1.3% -51.8% -40.4% -51.0% -44.2% -44.5% -37.6% -30.2% -42.0% -34.3% -27.4% -27.39%
Net Margin -72.0% -86.3% -1.1% -1.3% -1.9% -8.2% -77.5% -65.3% -1.2% -83.5% -67.7% -48.6% -27.1% -86.2% -16.9% 20.2% -33.4% -59.5% -57.9% -45.9% -45.85%
EBITDA Margin -58.1% -83.5% -94.8% -94.2% -1.4% -63.1% -80.8% -65.1% -1.1% -83.1% -62.7% -41.5% -15.3% -93.2% -40.3% -33.4% -30.8% -47.3% -44.0% -34.8% -34.77%
FCF Margin -29.4% -44.4% -62.4% -94.2% -1.1% -1.1% -87.3% -67.7% -59.8% -66.3% -70.7% -66.4% -56.7% -42.4% -38.6% -28.5% -27.4% -33.8% -27.4% -28.0% -28.01%
OCF Margin -22.6% -34.0% -50.8% -71.4% -84.3% -87.5% -68.7% -63.7% -57.2% -63.7% -69.8% -64.5% -54.7% -40.5% -37.0% -27.1% -26.8% -33.4% -27.1% -27.7% -27.70%
ROA 3Y Avg snapshot only -38.81%
ROIC 3Y Avg snapshot only -49.41%
ROIC Economic snapshot only -39.50%
Cash ROA snapshot only -27.16%
Cash ROIC snapshot only -48.70%
CROIC snapshot only -49.24%
NOPAT Margin snapshot only -26.36%
Pretax Margin snapshot only -50.02%
R&D / Revenue snapshot only 12.47%
SGA / Revenue snapshot only 91.79%
SBC / Revenue snapshot only 7.68%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -442.42 -148.35 -94.51 -53.66 -28.68 -41.08 -94.44 -119.50 -71.18 -34.41 -37.40 -29.70 -86.66 -48.34 -75.96 -176.37 -110.74 -97.90 -3.00 -1.29 -0.704
P/S Ratio 166.35 88.45 71.19 52.85 35.23 41.76 87.10 91.01 46.33 29.18 30.76 23.18 48.34 27.98 34.38 47.62 31.70 21.66 0.96 0.63 0.342
P/B Ratio 99.81 58.22 50.06 40.12 30.30 38.10 101.67 131.16 90.13 42.59 54.47 45.62 125.67 89.66 83.52 148.41 129.96 135.97 16.20 -31.28 -16.935
P/FCF -566.23 -199.23 -114.16 -56.10 -32.67 -38.85 -99.74 -134.41 -77.51 -44.02 -43.52 -34.90 -85.20 -65.96 -88.97 -167.18 -115.84 -64.00 -3.48 -2.25 -2.253
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -425.81 -156.91 -103.66 -63.71 -35.39 -44.53 -97.11 -111.30 -59.10 -34.85 -39.13 -32.43 -98.92 -53.24 -72.23 -104.78 -65.56 -58.87 -3.45 -3.12 -3.124
EV/Revenue 165.23 87.52 70.44 52.38 34.96 41.64 87.07 91.16 46.60 29.30 31.03 23.74 48.97 28.64 34.81 48.09 32.23 22.27 1.34 1.22 1.220
EV/EBIT -408.82 -152.07 -100.41 -61.71 -34.36 -43.09 -94.05 -106.94 -56.42 -32.66 -36.27 -29.78 -87.84 -48.79 -65.79 -95.41 -61.50 -54.38 -3.19 -2.93 -2.930
EV/FCF -562.42 -197.14 -112.95 -55.61 -32.42 -38.74 -99.71 -134.62 -77.96 -44.20 -43.90 -35.74 -86.30 -67.52 -90.09 -168.82 -117.78 -65.82 -4.87 -4.36 -4.356
Earnings Yield -0.2% -0.7% -1.1% -1.9% -3.5% -2.4% -1.1% -0.8% -1.4% -2.9% -2.7% -3.4% -1.2% -2.1% -1.3% -0.6% -0.9% -1.0% -33.3% -77.5% -77.54%
FCF Yield -0.2% -0.5% -0.9% -1.8% -3.1% -2.6% -1.0% -0.7% -1.3% -2.3% -2.3% -2.9% -1.2% -1.5% -1.1% -0.6% -0.9% -1.6% -28.7% -44.4% -44.38%
PEG Ratio snapshot only 0.010
EV/Gross Profit snapshot only 1.704
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 6.57 4.70 3.81 3.95 3.20 3.48 2.70 2.28 1.61 1.77 1.49 2.12 1.97 2.20 2.61 2.34 2.11 2.13 1.09 0.66 0.655
Quick Ratio 6.16 4.35 3.44 3.47 2.85 3.12 2.53 2.09 1.36 1.51 1.21 1.71 1.58 1.92 2.30 1.96 1.71 1.58 0.81 0.50 0.502
Debt/Equity 0.19 0.22 0.25 0.28 0.34 0.52 0.63 0.75 0.97 0.79 0.93 1.60 2.06 2.42 1.85 2.34 3.01 4.93 8.64 -35.07 -35.065
Net Debt/Equity -0.67 -0.61 -0.53 -0.35 -0.23 -0.11 -0.03 0.21 0.52 0.18 0.48 1.09 1.62 2.13 1.06 1.45 2.17 3.87 6.45 — —
Debt/Assets 0.14 0.15 0.16 0.19 0.21 0.29 0.32 0.35 0.38 0.34 0.37 0.50 0.56 0.57 0.53 0.56 0.59 0.66 0.47 0.69 0.694
Debt/EBITDA -0.83 -0.60 -0.52 -0.46 -0.40 -0.60 -0.60 -0.64 -0.64 -0.64 -0.66 -1.11 -1.60 -1.40 -1.58 -1.63 -1.49 -2.08 -1.32 -1.81 -1.812
Net Debt/EBITDA 2.88 1.67 1.11 0.56 0.28 0.13 0.03 -0.17 -0.34 -0.15 -0.34 -0.76 -1.26 -1.23 -0.90 -1.02 -1.08 -1.63 -0.98 -1.51 -1.508
Interest Coverage -46.13 -2341.59 — — — — -495.36 -411.15 -281.48 -193.08 -282.88 -96.29 -22.78 -14.93 -9.36 -7.48 -7.78 -5.81 -13.53 -11.05 -11.054
Equity Multiplier 1.35 1.43 1.50 1.50 1.59 1.79 1.98 2.18 2.57 2.29 2.49 3.19 3.68 4.27 3.49 4.14 5.07 7.48 18.49 -50.55 -50.546
Cash Ratio snapshot only 0.184
Debt Service Coverage snapshot only -10.369
Cash to Debt snapshot only 0.168
FCF to Debt snapshot only -0.396
Defensive Interval snapshot only 104.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.43 0.46 0.46 0.43 0.43 0.42 0.48 0.56 0.66 0.58 0.64 0.62 0.71 0.71 0.72 0.71 0.79 0.81 0.81 0.87 0.866
Inventory Turnover 3.19 2.88 2.39 2.55 3.25 3.39 4.37 4.42 4.37 3.63 4.05 3.15 3.51 2.59 2.58 2.29 2.18 2.64 2.88 2.86 2.857
Receivables Turnover 7.68 8.51 8.12 6.61 6.60 6.34 6.69 5.69 6.47 5.80 5.45 4.44 5.28 5.32 4.90 4.64 5.26 4.99 5.02 5.12 5.123
Payables Turnover 3.64 4.06 3.15 5.15 4.59 6.26 4.01 6.25 4.92 4.74 4.10 3.40 3.78 2.33 3.05 2.85 2.94 3.41 3.34 3.92 3.917
DSO 48 43 45 55 55 58 55 64 56 63 67 82 69 69 75 79 69 73 73 71 71.2 days
DIO 114 127 153 143 112 108 84 83 84 101 90 116 104 141 141 160 168 138 127 128 127.7 days
DPO 100 90 116 71 79 58 91 58 74 77 89 107 97 157 120 128 124 107 109 93 93.2 days
Cash Conversion Cycle 62 80 82 127 88 107 47 88 66 87 68 91 77 53 96 110 113 104 90 106 105.8 days
Fixed Asset Turnover snapshot only 2.093
Operating Cycle snapshot only 199.0 days
Cash Velocity snapshot only 8.433
Capital Intensity snapshot only 1.020
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 22.7% 3.3% -6.9% -17.4% -20.5% -21.7% -13.3% -3.8% 7.0% 5.3% -0.8% -5.2% -6.2% 4.8% 5.4% 9.6% 9.4% 4.1% 5.3% 3.1% 3.07%
Net Income -43.4% -2.1% -2.4% -2.4% -1.6% -33.6% -6.2% 25.6% 43.3% 12.2% 11.6% 2.8% 19.6% 28.5% 42.0% 62.1% 43.8% 60.2% 25.9% -86.8% -86.81%
EPS -37.4% -2.0% -2.4% -2.4% -1.6% -33.6% -5.7% 26.4% 44.3% 14.5% 28.8% 21.2% 34.5% 41.6% 48.2% 69.3% 51.3% 65.3% -13.3% -39.0% -38.96%
FCF -18.6% -1.5% -2.7% -2.1% -1.9% -89.7% -21.4% 30.9% 40.7% 35.1% 19.7% 6.9% 10.9% 33.0% 42.4% 53.0% 47.2% 16.9% 25.3% -1.4% -1.36%
EBITDA -58.3% -1.8% -1.8% -1.5% -1.0% -31.4% -14.4% 4.2% 14.6% 5.3% 12.3% 15.2% 41.1% 33.0% 35.9% 31.3% -8.7% 26.8% 15.4% 12.3% 12.28%
Op. Income -20.1% -1.2% -1.6% -1.5% -1.2% -38.6% -14.2% 4.2% 18.9% 0.3% 10.8% 15.4% 20.9% 47.0% 43.6% 36.8% 35.3% 14.6% 15.7% 22.1% 22.11%
OCF Growth snapshot only -5.43%
Asset Growth snapshot only -20.90%
Equity Growth snapshot only -1.06%
Debt Growth snapshot only -2.67%
Shares Change snapshot only -95.32%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 30.5% 26.7% 24.1% 19.8% 15.9% 12.3% 8.7% 5.0% 1.4% -5.2% -7.1% -9.0% -7.3% -4.8% -3.2% 0.0% 3.2% 4.7% 3.2% 2.3% 2.34%
Revenue 5Y 43.0% 38.1% 33.5% 28.3% 23.5% 19.3% 17.3% 14.8% 13.6% 10.9% 10.4% 9.4% 9.3% 9.4% 6.0% 3.8% 1.4% -1.5% -2.3% -3.2% -3.17%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 37.0% 33.7% 31.2% 23.5% 12.9% 5.9% -0.4% -2.3% -3.1% -10.0% -9.7% -11.3% -10.5% -3.6% -2.5% 2.5% 12.3% 13.1% 13.4% 11.5% 11.55%
Gross Profit 5Y 54.5% 48.3% 42.9% 35.9% 27.3% 18.4% 14.1% 11.2% 11.9% 10.5% 12.0% 11.5% 9.9% 12.1% 7.7% 5.5% 4.0% -1.7% -2.8% -4.1% -4.09%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 40.5% 39.8% 39.0% 35.7% 29.5% 32.2% 9.1% 2.1% -23.0% -16.0% -18.7% -18.4% -20.5% -19.1% -15.2% -12.3% -9.8% -11.3% -11.0% -10.2% -10.21%
Assets 5Y 54.3% 56.0% 58.6% 26.4% 22.9% 21.3% 15.2% 8.5% 6.8% 10.2% 8.7% 13.4% 10.8% 11.6% 2.8% -0.5% -15.2% -13.3% -14.2% -17.3% -17.31%
Equity 3Y 52.1% 54.6% 54.5% 60.3% 79.8% 1.2% 10.8% -0.3% -38.7% -33.5% -37.4% -39.2% -43.1% -43.8% -36.0% -37.5% -38.7% -44.9% -57.7% — —
Book Value 3Y 36.4% 39.5% 39.4% 45.1% 62.8% 1.0% 1.9% -6.4% -40.0% -35.1% -42.0% -43.6% -47.3% -47.9% -42.7% -45.9% -45.7% -51.3% 1.8% — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.96 0.93 0.92 0.85 0.77 0.64 0.64 0.56 0.51 0.27 0.25 0.19 0.27 0.31 0.31 0.43 0.24 0.08 0.26 0.34 0.338
Earnings Stability 0.28 0.29 0.35 0.46 0.51 0.56 0.53 0.41 0.29 0.47 0.40 0.34 0.07 0.23 0.09 0.00 0.00 0.01 0.02 0.04 0.042
Margin Stability 0.86 0.86 0.87 0.87 0.87 0.88 0.87 0.89 0.91 0.89 0.87 0.89 0.91 0.88 0.87 0.89 0.89 0.88 0.87 0.88 0.883
Rev. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.83 0.50 0.50 0.50 0.50 0.87 0.98 0.90 0.83 0.95 0.95 0.99 0.92 0.89 0.83 0.50 0.82 0.50 0.90 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 1.38 2.48 -0.06 -0.33 -0.87 -0.68 -0.76 -0.65 -0.63 -0.58 -0.65 -0.61 -0.29 -0.77 0.17 0.48 0.18 0.16 -4.12 — —
Gross Margin Trend 0.08 0.04 0.03 -0.03 -0.11 -0.16 -0.20 -0.17 -0.08 -0.03 0.03 0.07 0.07 0.17 0.15 0.12 0.15 0.02 -0.00 -0.00 -0.005
FCF Margin Trend 0.25 0.05 -0.22 -0.61 -0.78 -0.76 -0.48 -0.08 0.09 0.10 0.04 0.15 0.27 0.44 0.40 0.39 0.31 0.21 0.27 0.19 0.194
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.60 0.57 0.67 0.73 0.69 0.86 0.75 0.84 0.88 0.75 0.85 0.83 0.98 0.70 0.82 1.00 0.93 1.51 0.85 0.57 0.566
FCF/OCF 1.30 1.31 1.23 1.32 1.28 1.23 1.27 1.06 1.05 1.04 1.01 1.03 1.04 1.05 1.05 1.05 1.02 1.01 1.01 1.01 1.011
FCF/Net Income snapshot only 0.572
CapEx/Revenue 6.8% 10.4% 11.6% 22.8% 23.5% 20.0% 18.6% 4.0% 2.6% 2.6% 0.9% 1.9% 2.0% 1.9% 1.7% 1.4% 0.6% 0.4% 0.3% 0.3% 0.31%
CapEx/Depreciation snapshot only 0.121
Accruals Ratio -0.06 -0.12 -0.11 -0.12 -0.16 -0.06 -0.11 -0.07 -0.05 -0.12 -0.08 -0.08 -0.01 -0.12 -0.06 0.00 -0.01 0.09 -0.04 -0.18 -0.184
Sloan Accruals snapshot only -0.521
Cash Flow Adequacy snapshot only -88.960
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.1% -1.4% -1.3% -1.7% -0.7% -0.0% -0.5% -0.3% -0.5% 0.0% -15.2% -23.0% -22.95%
Total Shareholder Return -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.1% -1.4% -1.3% -1.7% -0.7% -0.0% -0.5% -0.3% -0.5% 0.0% -15.2% -23.0% -22.95%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.93 0.97 0.98 0.98 0.98 0.97 0.97 0.96 0.96 0.97 0.97 0.97 0.96 0.92 0.90 0.85 0.83 0.95 0.97 0.98 0.978
Interest Burden (EBT/EBIT) 1.00 1.07 1.10 1.18 1.23 1.09 1.03 0.93 0.82 0.97 0.99 1.01 1.04 1.07 0.95 0.63 0.65 0.57 0.79 1.20 1.201
EBIT Margin -0.40 -0.58 -0.70 -0.85 -1.02 -0.97 -0.93 -0.85 -0.83 -0.90 -0.86 -0.80 -0.56 -0.59 -0.53 -0.50 -0.52 -0.41 -0.42 -0.42 -0.416
Asset Turnover 0.43 0.46 0.46 0.43 0.43 0.42 0.48 0.56 0.66 0.58 0.64 0.62 0.71 0.71 0.72 0.71 0.79 0.81 0.81 0.87 0.866
Equity Multiplier 1.32 1.27 1.29 1.39 1.43 1.56 1.67 1.73 1.91 1.99 2.18 2.59 3.03 2.93 2.92 3.58 4.25 5.38 5.46 7.93 7.933
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.37 $-0.56 $-0.68 $-0.82 $-0.95 $-0.75 $-0.71 $-0.60 $-0.53 $-0.65 $-0.51 $-0.47 $-0.35 $-0.38 $-0.26 $-0.15 $-0.17 $-0.13 $-3.78 $-5.80 $-5.80
Book Value/Share $1.63 $1.44 $1.27 $1.09 $0.90 $0.81 $0.66 $0.55 $0.42 $0.52 $0.35 $0.31 $0.24 $0.20 $0.24 $0.17 $0.14 $0.09 $0.70 $-0.24 $-0.24
Tangible Book/Share $1.63 $1.33 $1.27 $1.09 $0.90 $0.71 $0.66 $0.55 $0.42 $0.43 $0.35 $0.31 $0.24 $0.13 $0.18 $0.12 $0.14 $0.04 $0.70 $-1.15 $-1.15
Revenue/Share $0.98 $0.95 $0.90 $0.83 $0.77 $0.74 $0.77 $0.79 $0.81 $0.76 $0.62 $0.61 $0.62 $0.65 $0.58 $0.54 $0.59 $0.59 $11.86 $11.85 $11.85
FCF/Share $-0.29 $-0.42 $-0.56 $-0.78 $-0.83 $-0.80 $-0.68 $-0.53 $-0.49 $-0.50 $-0.44 $-0.40 $-0.35 $-0.28 $-0.22 $-0.15 $-0.16 $-0.20 $-3.25 $-3.32 $-3.32
OCF/Share $-0.22 $-0.32 $-0.45 $-0.59 $-0.65 $-0.65 $-0.53 $-0.50 $-0.46 $-0.48 $-0.43 $-0.39 $-0.34 $-0.26 $-0.22 $-0.15 $-0.16 $-0.20 $-3.21 $-3.28 $-3.28
Cash/Share $1.41 $1.20 $0.99 $0.69 $0.52 $0.51 $0.44 $0.30 $0.19 $0.32 $0.16 $0.16 $0.10 $0.06 $0.19 $0.15 $0.12 $0.10 $1.53 $1.41 $1.41
EBITDA/Share $-0.38 $-0.53 $-0.61 $-0.68 $-0.76 $-0.69 $-0.69 $-0.65 $-0.64 $-0.64 $-0.49 $-0.44 $-0.31 $-0.35 $-0.28 $-0.25 $-0.29 $-0.22 $-4.59 $-4.63 $-4.63
Debt/Share $0.31 $0.32 $0.31 $0.31 $0.31 $0.42 $0.42 $0.41 $0.41 $0.41 $0.32 $0.49 $0.49 $0.49 $0.44 $0.40 $0.43 $0.46 $6.05 $8.39 $8.39
Net Debt/Share $-1.09 $-0.88 $-0.68 $-0.38 $-0.21 $-0.09 $-0.02 $0.11 $0.22 $0.09 $0.17 $0.34 $0.39 $0.43 $0.25 $0.25 $0.31 $0.36 $4.51 $6.98 $6.98
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -12.131
Altman Z-Prime snapshot only -31.171
Piotroski F-Score 5 2 1 1 1 1 2 4 4 4 4 3 3 5 4 3 5 2 5 4 4
Beneish M-Score -2.85 -2.85 -2.96 -2.63 -2.55 -2.45 -2.65 -2.72 -2.79 -5.87 -4.99 -3.67 -2.04 -3.03 -2.42 -2.50 -2.79 -1.83 -2.78 -3.65 -3.648
Ohlson O-Score snapshot only -1.499
Net-Net WC snapshot only $-7.32
EVA snapshot only $-11928010.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 59.52 59.28 73.35 73.88 74.04 73.81 60.20 60.13 56.13 58.03 55.89 57.24 54.31 55.69 58.25 55.68 53.95 44.22 15.35 14.95 14.951
Credit Grade snapshot only 17
Credit Trend snapshot only -40.727
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 5
Sector Credit Rank snapshot only 5

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms